PortfoliosLab logoPortfoliosLab logo
ZVRA vs. IAG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZVRA vs. IAG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zevra Therapeutics Inc. (ZVRA) and IAMGOLD Corporation (IAG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ZVRA achieves a 6.14% return, which is significantly higher than IAG's -13.95% return. Over the past 10 years, ZVRA has underperformed IAG with an annualized return of -17.62%, while IAG has yielded a comparatively higher 10.35% annualized return.


ZVRA

1D
-1.35%
1M
-31.14%
6M
5.67%
YTD
6.14%
1Y
-14.40%
3Y*
24.74%
5Y*
-1.18%
10Y*
-17.62%
ALL TIME*
-23.23%

IAG

1D
-2.54%
1M
-10.02%
6M
-21.95%
YTD
-13.95%
1Y
109.91%
3Y*
76.06%
5Y*
38.95%
10Y*
10.35%
ALL TIME*
5.33%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$76.33M$73.71M$89.43M
$18.33M$18.68M$21.76M

ZVRA vs. IAG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ZVRA
Zevra Therapeutics Inc.
6.14%7.43%27.33%42.70%-47.30%-22.23%84.70%-78.71%-56.05%37.29%
IAG
IAMGOLD Corporation
-13.95%219.57%103.95%-1.94%-17.57%-14.71%-1.61%1.36%-36.88%51.43%

Correlation

The correlation between ZVRA and IAG is 0.16, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.16

Correlation (3Y)
Balances recent behavior with more history.

0.12

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.10

Correlation (10Y)
Provides a long-term view across more market conditions.

0.07

Correlation (All Time)
Calculated using the full available price history since Apr 16, 2015

0.07

Fundamentals

Market Cap

ZVRA:

$562.18M

IAG:

$8.20B

EPS

ZVRA:

$2.15

IAG:

$1.73

PE Ratio

ZVRA:

4.43

IAG:

8.22

PS Ratio

ZVRA:

4.50

IAG:

2.43

PB Ratio

ZVRA:

2.78

IAG:

1.94

Total Revenue (TTM)

ZVRA:

$122.29M

IAG:

$3.42B

Gross Profit (TTM)

ZVRA:

$104.94M

IAG:

$1.64B

EBITDA (TTM)

ZVRA:

$149.15M

IAG:

$1.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZVRA vs. IAG — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ZVRA
ZVRA Risk / Return Rank: 3434
Overall Rank
ZVRA Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
ZVRA Sortino Ratio Rank: 3636
Sortino Ratio Rank
ZVRA Omega Ratio Rank: 3737
Omega Ratio Rank
ZVRA Calmar Ratio Rank: 3232
Calmar Ratio Rank
ZVRA Martin Ratio Rank: 3131
Martin Ratio Rank

IAG
IAG Risk / Return Rank: 8484
Overall Rank
IAG Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
IAG Sortino Ratio Rank: 8383
Sortino Ratio Rank
IAG Omega Ratio Rank: 8383
Omega Ratio Rank
IAG Calmar Ratio Rank: 8484
Calmar Ratio Rank
IAG Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ZVRA vs. IAG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Zevra Therapeutics Inc. (ZVRA) and IAMGOLD Corporation (IAG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ZVRAIAGDifference
Sharpe ratioReturn per unit of total volatility

-1.98

Sortino ratioReturn per unit of downside risk

-2.11

Omega ratioGain probability vs. loss probability

1.02

1.29

-0.27

Calmar ratioReturn relative to maximum drawdown

-0.36

2.55

-2.91

Martin ratioReturn relative to average drawdown

-0.65

5.35

-6.00

ZVRA vs. IAG - Sharpe Ratio Comparison

The current ZVRA Sharpe Ratio is -0.22, which is lower than the IAG Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of ZVRA and IAG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ZVRA vs. IAG - Drawdown Comparison

The maximum ZVRA drawdown since its inception was -99.27%, roughly equal to the maximum IAG drawdown of -95.55%. Use the drawdown chart below to compare losses from any high point for ZVRA and IAG.


Loading charts...

Drawdown Indicators


ZVRAIAGDifference

Max Drawdown

Largest peak-to-trough decline

-99.27%

-95.55%

-3.72%

Max Drawdown (1Y)

Largest decline over 1 year

-40.40%

-43.30%

+2.90%

Max Drawdown (3Y)

Largest decline over 3 years

-43.47%

-43.30%

-0.17%

Max Drawdown (5Y)

Largest decline over 5 years

-60.97%

-73.69%

+12.72%

Max Drawdown (10Y)

Largest decline over 10 years

-97.85%

-86.46%

-11.39%

Current Drawdown

Current decline from peak

-97.48%

-42.25%

-55.23%

Average Drawdown

Average peak-to-trough decline

-86.53%

-56.07%

-30.46%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.22%

20.61%

+1.61%

Volatility

ZVRA vs. IAG - Volatility Comparison

Zevra Therapeutics Inc. (ZVRA) has a higher volatility of 29.44% compared to IAMGOLD Corporation (IAG) at 15.14%. This indicates that ZVRA's price experiences larger fluctuations and is considered to be riskier than IAG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ZVRAIAGDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.44%

15.14%

+14.30%

Volatility (6M)

Calculated over the trailing 6-month period

49.17%

48.40%

+0.77%

Volatility (1Y)

Calculated over the trailing 1-year period

65.35%

62.98%

+2.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.11%

60.60%

+0.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

81.05%

58.53%

+22.52%

Dividends

ZVRA vs. IAG - Dividend Comparison

Neither ZVRA nor IAG has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ZVRA vs. IAG - Financials Comparison

This section allows you to compare key financial metrics between Zevra Therapeutics Inc. and IAMGOLD Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ZVRA and IAG have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZVRA has higher volatility (29.44%) compared to IAG (15.14%). In terms of maximum drawdown, ZVRA dropped -99.27% vs IAG's -95.55%.

IAG currently has the higher Sharpe Ratio (1.75 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ZVRA and IAG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer